Tumor Immunology and Immunotherapy Resistance

Dear Colleagues,

Over the last decade, there has been an increasing understanding of molecular mechanisms that regulate anti-tumor immune responses and an exponential increase in the use of novel cancer immunotherapies in various cancer types. Despite the demonstrated success of tumor immunotherapy, most patients do not respond, and there is also a development of resistance mechanisms in patients who initially respond to immunotherapies. The scope of this Special Issue aims to cover current knowledge, cutting-edge technologies, and prospects in tumor immunology and immunotherapies. We hope that the research and review articles in this Special Issue will provide valuable references for developing next-generation cancer immunotherapies.

Dr. Subbaya Subramanian
Dr. Timothy K. Starr
Dr. Xianda Zhao
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.